ARTICLE | Clinical News

HP-3150: Phase II/III started

WIR Staff

July 20, 2015 7:00 AM UTC

Hisamitsu began a placebo-controlled, Japanese Phase II/III trial to evaluate HP-3150 in patients with cancer pain. ...

Get Unlimited Access

Continue reading with a free trial.